TABLE 1.

Demographic and Outcome Data by Group

Characteristic	Control	Propranolol	p
n	20	25
Male/female	20/0	19/6	<0.05*
Age, y	30 ± 7	35 ± 7	0.18
Ethnicity
Black, n (%)	14 (70)	17 (68)	0.89
White, n (%)	6 (30)	8 (47)
Mechanism of injury
Blunt, n (%)	4 (20)	15 (60)	<0.05*
Penetrating, n (%)	17 (80)	10 (40)
ISS	31 ± 3	27 ± 3	0.31
Admission base deficit	−7.4 ± 1.5	−7.4 ± 1.4	0.99
Lactate, mg/dL	6 ± 1	5 ± 1	0.26
Initial HR, beats/min	111 ± 6	104 ± 4	0.47
Initial SBP, mm Hg	108 ± 7	113 ± 6	0.38
Admission GCS score	14 ± 1	13 ± 1	0.33
30-d mortality, n	0	0
pRBC transfusion, n (95% CI)	2.4 ± 0.6 (1.3–3.6)	2 ± 0.6 (0.88–3.1)	0.5
ICU LOS (95% CI), d	14 ± 4 (6–21)	9 ± 2 (6–12)	0.79
Ventilator days (95% CI)	11 ± 7 (4–17)	7 ± 2 (3.9–9.9)	0.97
Infections, n (%)
Pneumonia	13 (38)	11 (48)	0.64
Urinary tract infection	1 (3)	5 (22)	0.51
Wound infection	2 (6)	1 (4)	0.73
Bacteremia	4 (12)	1 (4)	0.35
Abdominal abscess	11 (32)	3 (13)	<0.05*

^*p < 0.05.

GCS, Glasgow Coma Scale; LOS, length of stay; pRBC, packed red blood cells.